Member Info for Laura2022

The bio techs that had these 4.35pm trades were

OBD SCLP OXB (Vulpes already has them) and APTA SBTX PYC (Vulpes had not had them in portfolio.....yet )

The other theory is some VCT fund buying UK bio techs due to macro/micro attractiveness?

Totally agree Jack

Must have been stop losses /algorithm etc

Many commentators and biontech companies are now saying the headwinds and R and D reticence of 2023 is now over, and a growth in bio tech now occurring in 2024 ...partic now that US and UK elections over

Labour UK government have committed huge investment in UK life science so maybe that is linked to these large trades

The bio techs that had these 4.35pm trades were

OBD SCLP OXB (Vulpes already has them) and APTA SBTX PYC (Vulpes had not had them in portfolio.....yet )

The other theory is some VCT fund buying UK bio techs due to macro/micro attractiveness?

Really not sure

The Vulpes was just coincidence when I saw a similar trade on SCLP and then someone mentioned Martin Diggle/Vulpes fund

Does seem too much coincidence that about 7 bio tech companies all had these large trades ....3 of whom are Vulpes

Or ..it could well be some coordinated VCT fund as per the Labour budget

Then sell up ?

"An update will be provided as appropriate FOLLOING its (independent review) conclusion."

* my capitals and brackets

Redacted

It's only been 3 days since the RNS

What else should they say?...that they haven't alread

They can't control the market reaction

It will...in my view...open up in auction above 60p ( see my point last night )

It's just a theory...and it will be on the Vulpes website if so

Other theory : part.of the Labour movement commitment to life sciences and some sort of VCT fund

Or : large new investor

This fund also has SCLP OBD OXB

On SCLP OXB and OBD there were grey trades at exactly the same time as PYC

Our Strategy

We seek value investments in underpriced UK biotech companies with strong, under-appreciated medical breakthroughs.

We use a hands-on activist approach to realise shareholder value and drive the business forward.

We use long term patient capital to invest in businesses where we have high conviction

SCLP have this investor...he also has investments in one of the other shares that.like PYC had a large trade. There was also a same trade on one of the other Vulpes fund biontechs

https://vulpesinvest.com/life-sciences-3/

Same happened on SCLP on Friday too...also oncology and where the Vulcas fund are

I suppose it doesn't matter who/what it is....more that someone has decided to take 2.5% of PYC

Yes

It appears the shenanigans were to allow a buyer and not a seller

Amd those who may have sold as a result will regret it

Thanks

Could u post that from advfn please

150p would be very welcome from here : ))

Maybe nothing...but UK office is Oxford...same as PYC

Vulpes Investment Management UK Ltd (United Kingdom)

3A Fountain House, Parkway Court, John Smith Drive, Oxford, OX4 2JY

Life Sciences

Science-led, hands-on, medical-health impact, curing disease

Our Strategy

We seek value investments in underpriced UK biotech companies with strong, under-appreciated medical breakthroughs.

We use a hands-on activist approach to realise shareholder value and drive the business forward.

We use long term patient capital to invest in businesses where we have high conviction